Inhibition profiles of human tissue kallikreins by serine protease inhibitors (original) (raw)

Abstract

Accumulated evidence has shown that human tissue kallikreins (hKs), a group of 15 homologous secreted serine proteases, are novel cancer biomarkers. We report here the inhibition profiles of selected hKs, including hK5, hK7, hK8, hK11, hK12, hK13, and hK14, by several common serine protease inhibitors (serpins) found in plasma. The association constants for the binding of serpins to kallikreins were determined and compared. Protein C inhibitor was found to be the fastest-binding serpin for most of these hKs. α2-Antiplasmin, α1-antichymotrypsin, and α1-antitrypsin also showed rapid inhibition of certain hKs. Kallistatin exhibited fast inhibition only with hK7. Our data demonstrate that these hKs are specifically regulated by certain serpins and their distinct inhibition profiles will be valuable aids in various aspects of kallikrein research.

:


Corresponding author liuyingl@rndsystems.com


References

Adham, I.M., Nayernia, K., and Engel, W. (1997). Spermatozoa lacking acrosin protein show delayed fertilization. Mol. Reprod. Dev.46, 370–376.10.1002/(SICI)1098-2795(199703)46:3<370::AID-MRD16>3.0.CO;2-2Search in Google Scholar

Borgono, C.A. and Diamandis, E.P. (2004). The emerging roles of human tissue kallikreins in cancer. Nat. Rev. Cancer4, 876–890.10.1038/nrc1474Search in Google Scholar

Chen, L.M., Chao, L., Mayfield, R.K., and Chao, J. (1990). Differential interactions of human kallikrein-binding protein and alpha 1-antitrypsin with human tissue kallikrein. Biochem. J.267, 79–84.10.1042/bj2670079Search in Google Scholar

Christensson, A. and Lilja, H. (1994). Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen. Eur. J. Biochem.220, 45–53.10.1111/j.1432-1033.1994.tb18597.xSearch in Google Scholar

Christensson, A., Laurell, C.B., and Lilja, H. (1990). Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur. J. Biochem.194, 755–763.10.1111/j.1432-1033.1990.tb19466.xSearch in Google Scholar

Deperthes, D., Chapdelaine, P., Tremblay, R.R., Brunet, C., Berton, J., Hebert, J., Lazure, C., and Dube, J.Y. (1995). Isolation of prostatic kallikrein hK2, also known as hGK-1, in human seminal plasma. Biochim. Biophys. Acta1245, 311–316.10.1016/0304-4165(95)00118-2Search in Google Scholar

Ecke, S., Geiger, M., and Binder, B.R. (1997). Heparin binding of protein-C inhibitor – analysis of the effect of heparin on the interaction of protein-C inhibitor with tissue kallikrein. Eur. J. Biochem.248, 475–480.10.1111/j.1432-1033.1997.00475.xSearch in Google Scholar

Espana, F., Fink, E., Sanchez-Cuenca, J., Gilabert, J., Estelles, A., and Witzgall, K. (1995). Complexes of tissue kallikrein with protein C inhibitor in human semen and urine. Eur. J. Biochem.234, 641–649.10.1111/j.1432-1033.1995.641_b.xSearch in Google Scholar

Hermans, J.M., Jones, R., and Stone, S.R. (1994). Rapid inhibition of the sperm protease acrosin by protein C inhibitor. Biochemistry33, 5440–5444.10.1021/bi00184a012Search in Google Scholar

Kapadia, C., Chang, A., Sotiropoulou, G., Yousef, G.M., Grass, L., Soosaipillai, A,, Xing, X., Howarth, D.H., and Diamandis, E.P. (2003). Human kallikrein 13, production and purification of recombinant protein and monoclonal and polyclonal antibodies, and development of a sensitive and specific immunofluorometric assay. Clin. Chem.49, 77–86.10.1373/49.1.77Search in Google Scholar

Klemm, U., Müller-Esterl, W., and Engel, W. (1991). Acrosin, the peculiar sperm-specific serine protease. Hum. Genet.87, 635–641.10.1007/BF00201716Search in Google Scholar

Laurell, M., Christensson, A., Abrahamsson, P.A., Stenflo, J., and Lilja, H. (1992). Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system. J. Clin. Invest.89, 1094–1101.Search in Google Scholar

Lovgren, J., Airas, K., and Lilja, H. (1999). Enzymatic action of human glandular kallikrein 2 (hK2). Substrate specificity and regulation by Zn2+ and extracellular protease inhibitors. Eur. J. Biochem.262, 781–789.Search in Google Scholar

Mikolajczyk, S.D., Millar, L.S., Kumar, A., and Saedi, M.S. (1998). Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors. Prostate34, 44–50.10.1002/(SICI)1097-0045(19980101)34:1<44::AID-PROS6>3.0.CO;2-KSearch in Google Scholar

Mikolajczyk, S.D., Millar, L.S., Kumar, A., and Saedi, M.S. (1999). Prostatic human kallikrein 2 inactivates and complexes with plasminogen activator inhibitor-1. Int. J. Cancer81, 438–442.10.1002/(SICI)1097-0215(19990505)81:3<438::AID-IJC18>3.0.CO;2-USearch in Google Scholar

Rahman, M.M., Worthy, K., Elson, C.J., Fink, E., Dieppe, P.A., and Bhoola, K.D. (1994). Inhibitor regulation of tissue kallikrein activity in the synovial fluid of patients with rheumatoid arthritis. Br. J. Rheumatol.33, 215–223.10.1093/rheumatology/33.3.215Search in Google Scholar

Salvesen, G.S. and Nagase, H. (2001). Inhibition of proteolytic enzymes. In: Proteolytic Enzymes, R. Beynon and J.S. Bond, eds. (Oxford, UK: Oxford University Press), pp. 105–147.Search in Google Scholar

Silverman, G.A., Bird, P.I., Carrell, R.W., Church, F.C., Coughlin, P.B., Gettins, P.G., Irving, J.A., Lomas, D.A., Luke, C.J., Moyer, R.W., et al. (2001). The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J. Biol. Chem.276, 33293–33296.10.1074/jbc.R100016200Search in Google Scholar

Stenman, U.H., Leinonen, J., Alfthan, H., Rannikko, S., Tuhkanen, K., and Alfthan, O. (1991). A complex between prostate-specific antigen and α1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res.51, 222–226.Search in Google Scholar

Travis, J. and Salvesen, G.S. (1983). Human plasma proteinase inhibitors. Annu. Rev. Biochem.52, 655–709.10.1146/annurev.bi.52.070183.003255Search in Google Scholar

Uhrin, P., Dewerchin M., Hilpert, M., Chrenek, P., Schofer, C., Zechmeister-Manchhart, M., Kronke, G., Vales A., Carmeliet, P., Binder, B.P., and Geiger, M. (2000). Disruption of the protein C inhibitor gene results in impaired spermatogenesis and male infertility. J. Clin. Invest.106, 1531–1539.10.1172/JCI10768Search in Google Scholar

Yousef, G.M. and Diamandis, E.P. (2001). The new human tissue kallikrein gene family, structure, function, and association to disease. Endocr. Rev.22, 184–204.Search in Google Scholar

Yousef, G.M., Polymeris, M.E., Grass, L., Soosaipillai, A., Chan, P.C., Scorilas, A., Borgono, C., Harbeck, N., Schmalfeldt, B., Dorn, J., et al. (2003). Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer. Cancer Res.63, 3958–3965.Search in Google Scholar

Zhou, G.X., Chao, L., and Chao, J. (1992). Kallistatin, a novel human tissue kallikrein inhibitor. Purification, characterization, and reactive center sequence. J. Biol. Chem.267, 25873–25880.Search in Google Scholar

Published Online: 2006-06-26

Published in Print: 2006-06-01

©2006 by Walter de Gruyter Berlin New York